利用口腔全身轴:癌症管理的新前沿
Anjana Parmar1, Palwinder Kaur2, Mandeep Kaur1
1School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Medical oncology (Northwood, London, England)
|July 19, 2025
概括
口腔微生物失调,口腔细菌的不平衡,与全身性疾病和癌症有关. 本综述探讨植物疗法作为一种潜在的治疗口腔病原体和癌症.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 口腔健康 口腔健康
背景情况:
- 口腔内有复杂的微生物群,对健康至关重要.
- 口腔中的微生物失衡 (失生症) 越来越多地与包括癌症在内的全身性疾病有关.
- 特定的口腔病原体及其机制可以启动致癌过程.
研究的目的:
- 阐明口腔微生物失生症在癌症发展中的作用.
- 确定特定的口腔病原体和促进瘤发生的机制.
- 探索具有抗口腔病原体和癌症活性的植物治疗药物.
主要方法:
- 文献综述侧重于口腔微生物群,失生症和癌症.
- 分析将口腔病原体与致癌途径联系起来的机制.
- 植物治疗剂的鉴定和评估.
主要成果:
- 口腔微生物失生症是癌症发病的一个重要因素.
- 某些口腔微生物及其通路与引发癌症有关.
- 植物治疗药物显示出对口腔病原体和癌细胞的潜在有效性.
结论:
- 口腔系统轴突出口腔健康和整体疾病之间的联系.
- 植物疗法为治疗口腔失生症和相关癌症提供了一个有希望的途径.
- 用植物治疗药物向口腔病原体可能会影响癌症的预防和治疗.
相关概念视频
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


